Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$1.55 - $2.23 $16,585 - $23,861
10,700 New
10,700 $16,000
Q4 2021

Feb 14, 2022

SELL
$7.29 - $9.5 $312,741 - $407,550
-42,900 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$4.22 - $12.48 $181,038 - $535,392
42,900 New
42,900 $381,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.